Lobe Sciences to Present Low-Dose L-130 Clinical Data at 9th Neuropsychiatric Drug Development Summit Sep 14, 2026 11:00PM
Lobe Sciences to Attend the ArcStone-Kingswood Growth Summit 2026 in Toronto Sep 14, 2026 08:00AM